Kirke Weaver - Feb 28, 2024 Form 4 Insider Report for Organon & Co. (OGN)

Role
Gen. Counsel & Corp. Secy.
Signature
/s/ Faye C. Brown, as Attorney-in-Fact for Kirke Weaver
Stock symbol
OGN
Transactions as of
Feb 28, 2024
Transactions value $
-$28,990
Form type
4
Date filed
3/1/2024, 04:24 PM
Previous filing
Feb 23, 2024
Next filing
Apr 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise +4.96K +32.65% 20.1K Feb 28, 2024 Direct F1
transaction OGN Common Stock Tax liability -$29K -1.61K -7.98% $18.04 18.5K Feb 28, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -4.96K -100% $0.00* 0 Feb 28, 2024 Common Stock 4.96K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit converts into one share of Organon & Co. common stock.
F2 As previously reported, these Restricted Stock Units vested on December 31, 2023, and shares of Organon & Co. common stock were distributed to the Reporting Person on February 28, 2024.